Saccharomyces boulardii as therapeutic alternative in experimental giardiasis.
J Appl Microbiol
; 131(1): 460-469, 2021 Jul.
Article
in En
| MEDLINE
| ID: mdl-33289232
ABSTRACT
AIMS:
The objective of this study was to evaluate the effect of treatment with the probiotic Saccharomyces boulardii with or without metronidazole in experimental giardiasis. METHODS ANDRESULTS:
The effect of treatment with S. boulardii with or without metronidazole on the intestinal mucosa, the antioxidant defence system and the parasitic load was determined in experimental giardiasis. Eight groups of animals with infection and/or treatment with the probiotic and/or drugs for 1 week after infection with Giardia lamblia were used. A reduction of approximately 90% in the parasitic load was observed in all the treated groups. Saccharomyces boulardii attenuated the damage caused by infection in the intestinal mucosa preserving its architecture and inhibiting the oxidative stress induced by parasite and metronidazole.CONCLUSIONS:
Saccharomyces boulardii was effective alone or in combination with metronidazole in resolving already established G. lamblia infection. SIGNIFICANCE AND IMPACT OF THE STUDY These results suggest the use of S. boulardii as an alternative treatment for giardiasis mainly in cases of resistance or intolerance to conventional treatment.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Giardiasis
/
Probiotics
/
Saccharomyces boulardii
/
Antiprotozoal Agents
Limits:
Animals
Language:
En
Journal:
J Appl Microbiol
Journal subject:
MICROBIOLOGIA
Year:
2021
Type:
Article
Affiliation country:
Brazil